Menu Search
Equities

Adicon Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
K0U:FRA

Adicon Holdings Ltd

Actions
  • Price (EUR)0.52
  • Today's Change-0.005 / -0.95%
  • Shares traded2.00
  • 1 Year change-44.39%
  • Beta--
Data delayed at least 15 minutes, as of Feb 17 2026 08:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Adicon Holdings Ltd is a holding company mainly engaged in the provision of independent clinical laboratory (ICL) services. The Company is engaged in the provision of medical testing, clinical trials, scientific research services, health management and pathology consultation services. The Company focuses on the development of core disease areas such as infectious diseases, women's health, solid tumors, perinatal & children's centers, and blood, covering many subjects such as internal medicine, pediatrics, obstetrics and gynecology, oncology, and neurology.

  • Revenue in HKD (TTM)3.08bn
  • Net income in HKD-30.88m
  • Incorporated2008
  • Employees5.15k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		9860:HKG since
announced		Transaction
value
Crown Bioscience IncAnnounced13 Nov 202513 Nov 2025Announced-24.26%204.00m
Suzhou Yuande Youqin Medical Laboratory Co LtdAnnounced06 May 202506 May 2025Announced-30.84%6.88m
Suzhou Yuande Weikang Biomedical Co LtdAnnounced06 May 202506 May 2025Announced-30.84%27.83m
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.